Provider Guidance for the Prevention of Respiratory Syncytial Virus in Infants: Maternal Vaccination Versus Infant Monoclonal Antibody Treatment
Obstet Gynecol Surv. 2024 Oct;79(10):585-590. doi: 10.1097/OGX.0000000000001324. ABSTRACT IMPORTANCE: In 2023, the Food and Drug Administration approved 2 new products to reduce the risk of …